Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Bruker Corporation    BRKR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 06:48pm CET

NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bruker Corporation ("Bruker" or the "Company") (NASDAQ: BRKR). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/brkr.

The investigation concerns whether Bruker and certain of its officers and/or directors have violated Sections federal securities laws.

On November 9, 2017, post-market, Bruker advised investors that on October 19, 2017, the Company received a notice of investigation and subpoena to produce documents from the U.S. Securities and Exchange Commission's ("SEC") Division of Enforcement. The SEC subpoena seeks information related to an employee terminated as part of a restructuring and matters involving Company policies, accounting practices related to revenue recognition and restructuring activities, as well as related financial reporting, disclosure and compliance matters since January 2013. The subpoena also seeks information on previously identified material weakness in internal controls over accounting for income taxes, related financial reporting matters and certain payments for non-employee travel expenses. Following this news, Bruker stock has dropped during intraday trading on November 10, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of Bruker, you can assist this investigation by visiting the firm's site: www.bgandg.com/brkr. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-bruker-corporation-brkr-300553939.html

SOURCE Bronstein, Gewirtz & Grossman, LLC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BRUKER CORPORATION
11/13 BRUKER CORPORATION : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Anno..
11/13 BRUKER : Announces Quarterly Dividend
11/10 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporat..
11/10 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corpo..
11/10 BRKR Law Offices of Howard G. Smith Commences Investigation on Behalf of Bruk..
11/10 GLANCY PRONGAY & MURRAY LLP : Commences Investigation on Behalf of Bruker Corpor..
11/09 BRUKER : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
11/02 BRUKER : tops Street 3Q forecasts
11/02 BRUKER CORP : Results of Operations and Financial Condition, Financial Statement..
11/02 BRUKER : Reports Third Quarter 2017 Financial Results
More news
News from SeekingAlpha
11/17 After Hours Gainers / Losers
11/13 Bruker declares $0.04 dividend
11/06 Bruker Corporation 2017 Q3 - Results - Earnings Call Slides
11/02 Bruker (BRKR) Q3 2017 Results - Earnings Call Transcript
11/02 Bruker beats by $0.03, beats on revenue